Type 1 regulatory T cells: A new mechanism of peripheral immune tolerance

Cellular and Molecular Immunology

Volumn 12, Issue 5, 2015, Pages 566-571

  Zeng, Hanyu ^a   Zhang, Rong ^a   Jin, Boquan ^a   Chen, Lihua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

biomarkers; clinical trials; regulatory functions; type 1 regulatory T cells

Indexed keywords

ALPHA2 INTEGRIN; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; LENTIVIRUS VECTOR; MEMBRANE PROTEIN; PROTEIN LAG 3; STAT3 PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; DISEASE ASSOCIATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; NONHUMAN; PERIPHERAL IMMUNE TOLERANCE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; TYPE 1 REGULATORY T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; DISEASES; IMMUNOLOGY; METABOLISM;

ANIMALS; BIOMARKERS; CLINICAL TRIALS AS TOPIC; DISEASE; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 84941106659     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2015.44     Document Type: Review

References (66)

1. Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 2013; 14: 307-308.
2. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-1240.
3. Groux H, OGarra A, Bigler M, Rouleau M, Antonenko S, de Vries JE et al. A CD41 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-742.
4. Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 2013; 19: 739-746.
5. Bacchetta R, Sartirana C, Levings MK, Bordignon C, Narula S, Roncarolo MG. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 2002; 32: 2237-2245.
6. El Mir S, Triebel F. A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens. J Immunol 2000; 164: 5583-5589.
7. Triebel F. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol 2003; 24: 619-622.
8. Kirchhofer D, Languino LR, Ruoslahti E, Pierschbacher MD. Alpha 2 beta 1 integrins from different cell types show different binding specificities. J Biol Chem 1990; 265: 615-618.
9. Elices MJ, Hemler ME. The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci U S A 1989; 86: 9906-9910.
10. Madamanchi A, Santoro SA, Zutter MM. alpha2beta1 Integrin. Adv Exp Med Biol 2014; 819: 41-60.
11. Kassiotis G, Gray D, Kiafard Z, Zwirner J, Stockinger B. Functional specialization of memory Th cells revealed by expression of integrin CD49b. J Immunol 2006; 177: 968-975.
12. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, Byrne MC. CD4(1)CD25(1) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311-323.
13. Cobbold SP, Nolan KF, Graca L, Castejon R, Le Moine A, Frewin M et al. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev 2003; 196: 109-124.
14. Kohyama M, Sugahara D, Sugiyama S, Yagita H, Okumura K, Hozumi N. Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc Natl Acad Sci U S A 2004; 101: 4192-4197.
15. Rahmoun M, Foussat A, Groux H, Pene J, Yssel H, Chanez P. Enhanced frequency of CD18-and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity. Int Arch Allergy Immunol 2006; 140: 139-149.
16. Schuler PJ, Saze Z, Hong CS, Muller L, Gillespie DG, Cheng D et al. Human CD41 CD391 regulatory T cells produce adenosine upon coexpression of surface CD73 or contact with CD731 exosomes or CD731 cells. Clin Exp Immunol 2014; 177: 531-543.
17. Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Jackson EK, Johnson JT et al. Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J Biol Chem 2010; 285: 27571-27580.
18. Bergmann C, Strauss L, Zeidler R, Lang S, Whiteside TL. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Cancer Res 2007; 67: 8865-8873.
19. Fousteri G, Jofra T, Di Fonte R, Gagliani N, Morsiani C, Stabilini A, Battaglia M. Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice. Diabetologia 2015; 58: 1319-1328.
20. Jin JO, Han X, Yu Q. Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J Autoimmun 2013; 40: 28-44.
21. Vasanthakumar A, Kallies A. IL-27 paves different roads to Tr1. Eur J Immunol 2013; 43: 882-885.
22. Kita H. Is ROG, repressor of GATA, a specific regulator of Th2-type immune response? Clin Immunol 2011; 139: 235-237.
23. Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T et al. The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus. J Immunol 2008; 181: 3897-3905.
24. Rani A, Afzali B, Kelly A, Tewolde-Berhan L, Hackett M, Kanhere AS et al. IL-2 regulates expression of C-MAF in human CD4 T cells. J Immunol 2011; 187: 3721-3729.
25. Benkhart EM, Siedlar M, Wedel A, Werner T, Ziegler-Heitbrock HW. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J Immunol 2000; 165: 1612-1617.
26. Yang Y, Ochando J, Yopp A, Bromberg JS, Ding Y. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation. J Immunol 2005; 174: 2720-2729.
27. Iwasaki Y, Fujio K, Okamura T, Yanai A, Sumitomo S, Shoda H et al. Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD41 T cells. Eur J Immunol 2013; 43: 1063-1073.
28. Okamura T, Fujio K, Shibuya M, Sumitomo S, Shoda H, Sakaguchi S, Yamamoto K. CD41CD25-LAG31 regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci U S A 2009; 106: 13974-13979.
29. Apetoh L, Quintana FJ, Pot C, Joller N, Xiao S, Kumar D et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 2010; 11: 854-861.
30. Pot C, Jin H, Awasthi A, Liu SM, Lai CY, Madan R et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 2009; 183: 797-801.
31. Wang H, Meng R, Li Z, Yang B, Liu Y, Huang F et al. IL-27 induces the differentiation of Tr1-like cells from human naive CD41 T cells via the phosphorylation of STAT1 and STAT3. Immunol Lett 2011; 136: 21-28.
32. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD41 cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388-392.
33. Wakkach A, Cottrez F, Groux H. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol 2001; 167: 3107-3113.
34. Sutavani RV, Bradley RG, Ramage JM, Jackson AM, Durrant LG, Spendlove I. CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype. J Immunol 2013; 191: 5895-5903.
35. Carrier Y, Whitters MJ, Miyashiro JS, LaBranche TP, Ramon HE, Benoit SE et al. Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells. Eur J Immunol 2012; 42: 1393-1404.
36. Zohar Y, Wildbaum G, Novak R, Salzman AL, Thelen M, Alon R et al. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. J Clin Invest 2014; 124: 2009-2022.
37. Hsu LH, Li KP, Chu KH, Chiang BL. A B-1a cell subset induces Foxp3 T cells with regulatory activity through an IL-10-independent pathway. Cell Mol Immunol 2014; 12: 354-365.
38. Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD251CD41 Tr cells. Blood 2005; 105: 1162-1169.
39. Andolfi G, Fousteri G, Rossetti M, Magnani CF, Jofra T, Locafaro G et al. Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(1) T cells. Mol Ther 2012; 20: 1778-1790.
40. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF et al. In vitro generation of interleukin 10-producing regulatory CD4(1) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 2002; 195: 603-616.
41. Chevalier MF, Didier C, Petitjean G, Karmochkine M, Girard PM, Barre-Sinoussi F et al. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD41 T cells. J Infect Dis 2015; 211: 769-779.
42. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003; 197: 451-460.
43. Waldmann H, Cobbold S. Regulating the immune response to transplants. A role for CD41 regulatory cells? Immunity 2001; 14: 399-406.
44. Himmel ME, Yao Y, Orban PC, Steiner TS, Levings MK. Regulatory Tcell therapy for inflammatory bowel disease: more questions than answers. Immunology 2012; 136: 115-122.
45. Kennedy A, Schmidt EM, Cribbs AP, Penn H, Amjadi P, SyedK et al. A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells. Eur J Immunol 2014; 44: 2968-2978.
46. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010; 463: 808-812.
47. Kim HP, Leonard WJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 2007; 204: 1543-1551.
48. Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008; 38: 1654-1663.
49. Le Buanec H, Gougeon ML, Mathian A, Lebon P, Dupont JM, Peltre G et al. IFN-alpha and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells. Proc Natl Acad Sci U S A 2011; 108: 18995-19000.
50. Pellerin L, Jenks JA, Begin P, Bacchetta R, Nadeau KC. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 2014; 58: 358-368.
51. Decker D, Epple E, Becker J, Weller R. [Measuring method for the X-ray cine-densitometry of moving vessels (authors transl)]. Biomed Tech (Berl) 1976; 21: 179-185.
52. Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010; 116: 935-944.
53. Manavalan JS, Rossi PC, Vlad G, Piazza F, Yarilina A, Cortesini R et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 2003; 11: 245-258.
54. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166: 5530-5539.
55. Magnani CF, Alberigo G, Bacchetta R, Serafini G, Andreani M, Roncarolo MG et al. Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. Eur J Immunol 2011; 41: 1652-1662.
56. Gregori S, Goudy KS, Roncarolo MG. The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells. Front Immunol 2012; 3: 30.
57. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP31 regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
58. Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M. Resting dendritic cells induce peripheral CD81 T cell tolerance through PD-1 and CTLA-4. Nat Immunol 2005; 6: 280-286.
59. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010; 236: 219-242.
60. Gagliani N, Jofra T, Stabilini A, Valle A, Atkinson M, Roncarolo MG et al. Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes 2010; 59: 433-439.
61. Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 2012; 8: e1002714.
62. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohns disease. Clin Gastroenterol Hepatol 2006; 4: 754-759.
63. Bacchetta R, Lucarelli B, Sartirana C, Gregori S, Lupo Stanghellini MT, Miqueu P et al. Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells. Front Immunol 2014; 5:16.
64. Ciceri F, Labopin M, Aversa F, Rowe JM, Bunjes D, Lewalle P et al. A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. Blood 2008; 112: 3574-3581.
65. Aversa F, Martelli MF. Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases. Springer Semin Immunopathol 2004; 26: 155-168.
66. Hardenberg G, Steiner TS, Levings MK. Environmental influences on T regulatory cells in inflammatory bowel disease. Semin Immunol 2011; 23: 130-138.